Home LiteratureArticle Details
PMID: 4372682 Published · ppublish English Journal Article

Reversal of catecholamine refractoriness by inhibitors of RNA and protein synthesis.

Science (New York, N.Y.) ·Vol. 186 ·No. 4170 ·1974-12-27 ·Pages 1221-3

DeVellis J, Brooker G

Abstract

The generation of adenosine 3',5'-monophosphate (cyclic AMP) in response to catecholamines in the 2B subclone of RGC6 rat glioma cells previously exposed to norepinephrine and refractory to further norepinephrine addition is substantially increased by addition of inhibitors of RNA and protein synthesis. The time course of the effect of these inhibitors on cyclic AMP concentration suggests that rapid protein synthesis and turnover are involved in catecholamine refractoriness. Norepinephrine induction of cyclic nucleotide phosphodiesterase is demonstrable in RGC6 cells but not in the 2B subclone. Thus, catecholamine refractoriness cannot be attributed to induction of phosphodiesterase. This implies that induction of a protein or proteins, important in catecholamine refractoriness, affects the synthesis rather than the degradation of cyclic AMP.

MeSH Terms
Animals Cell Line Clone Cells Cyclic AMP/biosynthesis Cycloheximide/analogs & derivatives,pharmacology Dactinomycin/pharmacology Epinephrine/pharmacology Glioma Phosphoric Diester Hydrolases/metabolism Rats Stimulation, Chemical Time Factors
Chemicals
Dactinomycin Cycloheximide Cyclic AMP Phosphoric Diester Hydrolases Epinephrine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
DeVellis J
Brooker G
Article Info
Journal
Science (New York, N.Y.)
Abbr.
Science
ISSN
0036-8075
Published
1974-12-27
Pages
1221-3
Language
English
Region
United States
NLM ID
0404511
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com